Peptide Atlas · Peptide

Selank

Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, reported to have prolonged anti-anxiety and nootropic effects.

preclinical

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Selank' with aliases Selank acetate, TP-7, tuftsin analog (modified) · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 11765600: Selank, C33H57N11O9, 751.9 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 129954-34-3. · 2026-09-27 04:00 · somebody
fact added identity: IUPAC name: (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrro · 2026-09-27 04:00 · somebody
fact added summary: Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, reported to have prolonged anti-anxiety and nootropic effects. · 2026-09-27 04:00 · somebody
fact added mechanism: In radioligand studies it acted as a positive allosteric modulator of GABA binding. · 2026-09-27 04:00 · somebody
fact added mechanism: It dose-dependently inhibited the enzymatic breakdown of plasma enkephalin (IC50 15 micromolar), more potently than the · 2026-09-27 04:00 · somebody
citation added pmid 30255741 cited as preclinical: Selank as a positive allosteric modulator of GABA binding · 2026-09-27 04:00 · somebody
citation added pmid 11550013 cited as preclinical: Selank inhibits enkephalin-degrading enzymes · 2026-09-27 04:00 · somebody

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.